Evidence map›Paper›PMID 42151624›Full record

ArticleImmunogenetics2026

Identification of gene conversion events in horse IGHV suggests preferential hotspots for diversification.

Juliana Edelvacy Lima Pinto, João Henrique Brandão Gervásio, Joseph Chi-Fung Ng, Adriano Gomes-Silva, Herbert L de Matos Guedes, Luiz Cunha, Leda R Castilho, Jerson Lima da Silva, Glória Regina Franco, Carlena Navas and 1 more

Abstract read
In one paragraph

Article in Immunogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Juliana Edelvacy Lima PintoLaboratory of Synthetic Biology and Biomimetics, Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
João Henrique Brandão GervásioLaboratory of Synthetic Biology and Biomimetics, Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Joseph Chi-Fung NgResearch Department of Structural and Molecular Biology, University College London, London, WC1E 6BT, UK.
Adriano Gomes-SilvaInterdisciplinary Laboratory of Medical Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Herbert L de Matos GuedesLaboratory of Immunobiotechnology, Department of Immunology, Paulo de Góes Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Luiz CunhaVital Brazil Institute, Niterói, RJ, Brazil.
Leda R CastilhoCell Culture Engineering Laboratory, COPPE, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Jerson Lima da SilvaInstitute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Glória Regina FrancoLaboratory of Biochemical Genetics, Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Federal University of Minas Gerais, Belo Horizonte, MG, 30161-970, Brazil.
Carlena NavasLaboratory of Synthetic Biology and Biomimetics, Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Liza Figueiredo FelicoriLaboratory of Synthetic Biology and Biomimetics, Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Federal University of Minas Gerais, Belo Horizonte, MG, Brazil. lizaffelicori@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The humoral immune response relies on a diverse antibody repertoire, which is expanded through processes such as somatic hypermutation, class-switch recombination and gene conversion. These processes are primarily mediated by activation-induced cytidine deaminase (AID). Gene conversion generates diversity in immunoglobulin heavy and light chains (IGHVs) in species such as chickens and rabbits, though it has not been widely studied. Since 80% of the equine IGHV repertoire originates from only three functional gene segments, we examined gene conversion events in horses to assess their role in antibody diversification. Using a modified version of BrepConvert, which optimized analysis time, we identified gene conversion events in 6.9% of immunoglobulin sequences. The results showed a local preference, with most events occurring at the beginning of framework region 1 (FR1) and within complementarity-determining region 2 (CDR2). Pseudogenes IGHV4-35, IGHV4-53, and IGHV4-38 were utilized most frequently, while functional genes IGHV4-21, IGHV4-22, and IGHV4-29 exhibited the highest event frequencies. Interestingly, while most mismatched regions were only three nucleotides long, 91% of these events are flanked by specific sequences (six nucleotides at the 5' end and one nucleotide at the 3' end). Furthermore, functional pseudogene pairs often share identical leader regions of 5-26 nucleotides, suggesting expanded events. We also identified a potential association between these events and local non-B DNA conformations, as well as with the zinc finger protein ZNF691, which supports the involvement of DNA-binding factors. Together, these findings demonstrate that gene conversion significantly contributes to equine antibody diversity by targeting specific IGHV regions.

Indexed as

Antibody DiversityGene ConversionImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionAnimalsCytidine DeaminaseHorsesPseudogenesCytidine DeaminaseImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionAntibody RepertoireDiversityGene ConversionImmunoglobulinPseudogenes

Identifiers

PMID42151624
PMCPMC13183705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.